A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

Draft amendments to the Drugs Rules would remove duplicate viral tests on finished plasma-derived medicines once source plasma is verified as safe, aimed at accelerating production of critical ...

HIV-seq identifies key differences in HIV-infected cells before and after starting antiretroviral therapy to support treatment research.

While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in the city found that only ...

This case has exposed systemic weaknesses in Uganda’s medical laboratory sector, raising concerns about test accuracy, competence, and ethics. Medical laboratory tests are central to diagnosing ...

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

Scientists at Gladstone Institutes, in collaboration with a team at the San Francisco Veterans Affairs Medical Center, have developed a novel tool—named HIV-seq—for profiling the features of rare ...

The World Health Organization (WHO) is issuing, for the first time, recommendations on new near-point-of-care (NPOC) ...

Katherine Stueland is the CEO of GeneDx, who led the company from a financially challenged phase to profitability in just 3 years. Currently, she leads efforts ...

The approach relies on a specially engineered scaffold that links three naturally occurring cytokines known to promote immune memory.